141 related articles for article (PubMed ID: 27859426)
1. Muscle fiber type proportion and size is not altered in mcardle disease.
Henning F; Cunninghame CA; Martín MA; Rubio JC; Arenas J; Lucia A; HernáNdez-Laín A; Kohn TA
Muscle Nerve; 2017 Jun; 55(6):916-918. PubMed ID: 27859426
[TBL] [Abstract][Full Text] [Related]
2. Muscle diffusion tensor imaging in glycogen storage disease V (McArdle disease).
Rehmann R; Schlaffke L; Froeling M; Kley RA; Kühnle E; De Marées M; Forsting J; Rohm M; Tegenthoff M; Schmidt-Wilcke T; Vorgerd M
Eur Radiol; 2019 Jun; 29(6):3224-3232. PubMed ID: 30560358
[TBL] [Abstract][Full Text] [Related]
3. Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.
Krag TO; Pinós T; Nielsen TL; Brull A; Andreu AL; Vissing J
J Neuropathol Exp Neurol; 2016 May; 75(5):441-54. PubMed ID: 27030740
[TBL] [Abstract][Full Text] [Related]
4. Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro.
de Luna N; Brull A; Guiu JM; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
Dis Model Mech; 2015 May; 8(5):467-72. PubMed ID: 25762569
[TBL] [Abstract][Full Text] [Related]
5. Genes and exercise intolerance: insights from McArdle disease.
Nogales-Gadea G; Godfrey R; Santalla A; Coll-Cantí J; Pintos-Morell G; Pinós T; Arenas J; Martín MA; Lucia A
Physiol Genomics; 2016 Feb; 48(2):93-100. PubMed ID: 26465709
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic power of the non-ischaemic forearm exercise test in detecting glycogenosis type V.
Hogrel JY; van den Bogaart F; Ledoux I; Ollivier G; Petit F; Koujah N; Béhin A; Stojkovic T; Eymard B; Voermans N; Laforêt P
Eur J Neurol; 2015 Jun; 22(6):933-40. PubMed ID: 25740218
[TBL] [Abstract][Full Text] [Related]
7. McArdle disease does not affect skeletal muscle fibre type profiles in humans.
Kohn TA; Noakes TD; Rae DE; Rubio JC; Santalla A; Nogales-Gadea G; Pinós T; Martín MA; Arenas J; Lucia A
Biol Open; 2014 Nov; 3(12):1224-7. PubMed ID: 25432515
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiles of exercise in patients with McArdle disease or mitochondrial myopathy.
Delaney NF; Sharma R; Tadvalkar L; Clish CB; Haller RG; Mootha VK
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8402-8407. PubMed ID: 28716914
[TBL] [Abstract][Full Text] [Related]
9. Low survival rate and muscle fiber-dependent aging effects in the McArdle disease mouse model.
Real-Martinez A; Brull A; Huerta J; Tarrasó G; Lucia A; Martin MA; Arenas J; Andreu AL; Nogales-Gadea G; Vissing J; Krag TO; de Luna N; Pinós T
Sci Rep; 2019 Mar; 9(1):5116. PubMed ID: 30914683
[TBL] [Abstract][Full Text] [Related]
10. McArdle Disease: New Insights into Its Underlying Molecular Mechanisms.
Llavero F; Arrazola Sastre A; Luque Montoro M; Gálvez P; Lacerda HM; Parada LA; Zugaza JL
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775340
[TBL] [Abstract][Full Text] [Related]
11. Excessive skeletal muscle recruitment during strenuous exercise in McArdle patients.
Rae DE; Noakes TD; San Juan AF; Pérez M; Nogales-Gadea G; Ruiz JR; Morán M; Martín MA; Andreu AL; Arenas J; Lucia A
Eur J Appl Physiol; 2010 Nov; 110(5):1047-55. PubMed ID: 20683610
[TBL] [Abstract][Full Text] [Related]
12. Differential glucose metabolism in mice and humans affected by McArdle disease.
Krag TO; Pinós T; Nielsen TL; Duran J; García-Rocha M; Andreu AL; Vissing J
Am J Physiol Regul Integr Comp Physiol; 2016 Aug; 311(2):R307-14. PubMed ID: 27280431
[TBL] [Abstract][Full Text] [Related]
13. Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.
Brull A; de Luna N; Blanco-Grau A; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
J Physiol; 2015 Jun; 593(12):2693-706. PubMed ID: 25873271
[TBL] [Abstract][Full Text] [Related]
14. Permanent muscle weakness in McArdle disease.
Nadaj-Pakleza AA; Vincitorio CM; Laforêt P; Eymard B; Dion E; Teijeira S; Vietez I; Jeanpierre M; Navarro C; Stojkovic T
Muscle Nerve; 2009 Sep; 40(3):350-7. PubMed ID: 19670320
[TBL] [Abstract][Full Text] [Related]
15. [Morphological and biochemical studies on glycogenosis type V (McArdle) (author's transl)].
Pongratz D; Schaub J; Koppenwallner C; Hübner G
Klin Wochenschr; 1981 Sep; 59(18):1053-9. PubMed ID: 6795385
[TBL] [Abstract][Full Text] [Related]
16. Selective atrophy of type 1 muscle fibers in McArdle's disease.
Felice KJ; Grunnet ML; Sima AA
Neurology; 1996 Aug; 47(2):581-3. PubMed ID: 8757045
[TBL] [Abstract][Full Text] [Related]
17. PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
de Luna N; Brull A; Lucia A; Santalla A; Garatachea N; Martí R; Andreu AL; Pinós T
Neuromuscul Disord; 2014 Dec; 24(12):1079-86. PubMed ID: 25240406
[TBL] [Abstract][Full Text] [Related]
18. [McArdle disease (gycogenosis type V): analysis of clinical, biological and genetic features of five French patients].
Delmont E; Sacconi S; Berge-Lefranc JL; Aquaron R; Butori C; Desnuelle C
Rev Neurol (Paris); 2008 Nov; 164(11):912-6. PubMed ID: 18808785
[TBL] [Abstract][Full Text] [Related]
19. Genotypic and phenotypic features of McArdle disease: insights from the Spanish national registry.
Lucia A; Ruiz JR; Santalla A; Nogales-Gadea G; Rubio JC; García-Consuegra I; Cabello A; Pérez M; Teijeira S; Vieitez I; Navarro C; Arenas J; Martin MA; Andreu AL
J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):322-8. PubMed ID: 22250184
[TBL] [Abstract][Full Text] [Related]
20. Low aerobic capacity in McArdle disease: A role for mitochondrial network impairment?
Villarreal-Salazar M; Santalla A; Real-Martínez A; Nogales-Gadea G; Valenzuela PL; Fiuza-Luces C; Andreu AL; Rodríguez-Aguilera JC; Martín MA; Arenas J; Vissing J; Lucia A; Krag TO; Pinós T
Mol Metab; 2022 Dec; 66():101648. PubMed ID: 36455789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
